Markus Heep, MD, is currently the Medical Director at BioNTech, focusing on the clinical development of BNT331, an innovative treatment for bacterial vaginosis. With over 25 years of experience in anti-infectives development, Markus has held key positions in CROs, NGOs, biotech firms, and large pharmaceutical companies. They previously worked as a Medical Director in various organizations, contributing expertise to the design and management of clinical trials for a range of infections. Markus started their medical training as a Junior House Officer at University Hospital Mainz and has also served as a board-certified Medical Microbiologist.
Location
Freiburg, Germany
This person is not in any offices